Electrolyte Blood Press.  2017 Sep;15(1):17-22. 10.5049/EBP.2017.15.1.17.

Renal Tubular Acidosis in Patients with Primary Sjögren's Syndrome

Affiliations
  • 1Department of Medicine, Graduate School, Kyung Hee University, Seoul, Korea.
  • 2Division of Nephrology, Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Korea. khjeong@khu.ac.kr
  • 3Divison of Nephrology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea.

Abstract

Primary Sjögren's syndrome (pSS) is characterized by lymphocytic infiltration of the exocrine glands resulting in decreased saliva and tear production. It uncommonly involves the kidneys in various forms, including tubulointerstitial nephritis, renal tubular acidosis, Fanconi syndrome, and rarely glomerulonephritis. Its clinical symptoms include muscle weakness, periodic paralysis, and bone pain due to metabolic acidosis and electrolyte imbalance. Herein, we describe the cases of two women with pSS whose presenting symptoms involve the kidneys. They had hypokalemia and normal anion gap metabolic acidosis due to distal renal tubular acidosis and positive anti-SS-A and anti-SS-B autoantibodies. Since one of them experienced femoral fracture due to osteomalacia secondary to renal tubular acidosis, an earlier diagnosis of pSS is important in preventing serious complications.

Keyword

Sjögren's syndrome; Osteomalacia; Renal tubular acidosis; Hypokalemia

MeSH Terms

Acid-Base Equilibrium
Acidosis
Acidosis, Renal Tubular*
Autoantibodies
Diagnosis
Exocrine Glands
Fanconi Syndrome
Female
Femoral Fractures
Glomerulonephritis
Humans
Hypokalemia
Kidney
Muscle Weakness
Nephritis, Interstitial
Osteomalacia
Paralysis
Saliva
Tears
Autoantibodies

Figure

  • Fig. 1 Mild interstitial inflammation with tubular injury (PAS stain, original magnification ×200)


Reference

1. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine. Sjögren's Syndrome. 18th ed. New York: McGraw-Hill;2012. p. 2770–2773.
2. Goules AV, Tatouli IP, Moutsopoulos HM, Tzioufas AG. Clinically significant renal involvement in primary Sjogren's syndrome: clinical presentation and outcome. Arthritis Rheum. 2013; 65:2945–2953. PMID: 24166794.
3. Seror R, Ravaud P, Bowman SJ, et al. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis. 2010; 69:1103–1109. PMID: 19561361.
4. Francois H, Mariette X. Renal involvement in primary Sjogren syndrome. Nat Rev Nephrol. 2016; 12:82–93. PMID: 26568188.
5. Yilmaz H, Kaya M, Ozbek M, K UU, Safa Yildirim I. Hypokalemic periodic paralysis in Sjogren's syndrome secondary to distal renal tubular acidosis. Rheumatol Int. 2013; 33:1879–1882. PMID: 22212410.
Article
6. Han JS, Kim GH, Kim J, et al. Secretory-defect distal renal tubular acidosis is associated with transporter defect in H(+)-ATPase and anion exchanger-1. J Am Soc Nephrol. 2002; 13:1425–1432. PMID: 12039970.
Article
7. Walsh S, Turner CM, Toye A, et al. Immunohistochemical comparison of a case of inherited distal renal tubular acidosis (with a unique AE1 mutation) with an acquired case secondary to autoimmune disease. Nephrol Dial Transplant. 2007; 22:807–812. PMID: 17205967.
Article
8. Kim HY, Kim SS, Bae EH, Ma SK, Kim SW. Decreased Renal Expression of H(+)-ATPase and Pendrin in a Patient with Distal Renal Tubular Acidosis Associated with Sjogren's Syndrome. Intern Med. 2015; 54:2899–2904. PMID: 26568006.
9. Khandelwal D, Bhattacharya S, Gadodia A, Khadgawat R, Tandon N, Ammini AC. Metabolic bone disease as a presenting manifestation of primary Sjogren's syndrome: Three cases and review of literature. Indian J Endocrinol Metab. 2011; 15:341–345. PMID: 22029009.
10. Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014; 29:1–23. PMID: 23712442.
Article
11. Fulop M, Mackay M. Renal tubular acidosis, Sjogren syndrome, and bone disease. Arch Intern Med. 2004; 164:905–909. PMID: 15111378.
12. Geng Y, Zhao Y, Zhang Z. Tubulointerstitial nephritis-induced hypophosphatemic osteomalacia in Sjogren's syndrome: a case report and review of the literature. Clin Rheumatol. 2017.
13. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002; 61:554–558. PMID: 12006334.
Article
14. Maripuri S, Grande JP, Osborn TG, et al. Renal involvement in primary Sjogren's syndrome: a clinicopathologic study. Clin J Am Soc Nephrol. 2009; 4:1423–1431. PMID: 19679669.
Full Text Links
  • EBP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr